IQVIA HOLDINGS INC. Goodwill and Intangible Asset Impairment
IQVIA HOLDINGS INC. (IQV) reported Goodwill and Intangible Asset Impairment of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GoodwillAndIntangibleAssetImpairment · last filed 2020-02-18
- IQVIA HOLDINGS INC. goodwill and intangible asset impairment for the quarter ending 2017-12-31 was $0.00.
- IQVIA HOLDINGS INC. goodwill and intangible asset impairment for the quarter ending 2017-09-30 was $0.00.
- IQVIA HOLDINGS INC. goodwill and intangible asset impairment for the quarter ending 2016-12-31 was $0.00.
- IQVIA HOLDINGS INC. goodwill and intangible asset impairment for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- IQVIA HOLDINGS INC. goodwill and intangible asset impairment for fiscal 2017 was $40.00M, a 42.86% increase from fiscal 2016.
- IQVIA HOLDINGS INC. goodwill and intangible asset impairment for fiscal 2016 was $28.00M.
| Period end | Goodwill and Intangible Asset Impairment 3 month | Goodwill and Intangible Asset Impairment 6 month | Goodwill and Intangible Asset Impairment 9 month | Goodwill and Intangible Asset Impairment 9 month as first filed | Goodwill and Intangible Asset Impairment 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2020-02-18 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $0.00 derived: sum of 2 quarters · filed 2020-02-18 | $40.00M 10-K · filed 2020-02-18 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $40.00M 10-Q · filed 2018-10-25 | |||
| 2017-06-30 | $40.00M 10-Q · filed 2018-07-27 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $28.00M 10-K · filed 2019-02-19 | |||
| 2016-09-30 | $28.00M 10-Q · filed 2017-10-27 | $27.94M 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |